Vanguard Group Inc. Buys 66,215 Shares of Masimo Co. (NASDAQ:MASI)

Vanguard Group Inc. raised its holdings in Masimo Co. (NASDAQ:MASI - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,586,702 shares of the medical equipment provider's stock after acquiring an additional 66,215 shares during the period. Vanguard Group Inc. owned about 8.57% of Masimo worth $758,182,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. BNP Paribas Financial Markets boosted its holdings in shares of Masimo by 76.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 19,982 shares of the medical equipment provider's stock valued at $2,664,000 after acquiring an additional 8,656 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Masimo during the third quarter valued at about $4,120,000. Rockefeller Capital Management L.P. boosted its stake in shares of Masimo by 4.2% during the third quarter. Rockefeller Capital Management L.P. now owns 137,393 shares of the medical equipment provider's stock valued at $18,321,000 after purchasing an additional 5,541 shares in the last quarter. Verition Fund Management LLC bought a new stake in shares of Masimo during the third quarter worth about $245,000. Finally, Fred Alger Management LLC acquired a new position in shares of Masimo in the third quarter valued at approximately $595,000. Institutional investors and hedge funds own 85.96% of the company's stock.

Insider Activity at Masimo

In related news, COO Bilal Muhsin sold 30,000 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the transaction, the chief operating officer now directly owns 24,172 shares of the company's stock, valued at approximately $4,048,568.28. This represents a 55.38 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig B. Reynolds sold 2,053 shares of the firm's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $166.13, for a total value of $341,064.89. Following the completion of the sale, the director now directly owns 16,581 shares of the company's stock, valued at $2,754,601.53. This trade represents a 11.02 % decrease in their position. The disclosure for this sale can be found here. 9.70% of the stock is owned by corporate insiders.

Remove Ads

Analyst Ratings Changes

MASI has been the topic of a number of research reports. Raymond James boosted their target price on shares of Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a report on Friday, December 27th. Wells Fargo & Company lifted their target price on Masimo from $193.00 to $205.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Piper Sandler upped their price target on Masimo from $210.00 to $215.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Finally, Needham & Company LLC restated a "hold" rating on shares of Masimo in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $194.80.

Masimo Trading Up 0.6 %

MASI stock traded up $1.01 during midday trading on Tuesday, hitting $167.61. The stock had a trading volume of 373,879 shares, compared to its average volume of 638,636. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The business has a fifty day moving average price of $174.67 and a two-hundred day moving average price of $162.10. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $194.88. The firm has a market cap of $9.06 billion, a P/E ratio of 115.59 and a beta of 1.04.

Masimo (NASDAQ:MASI - Get Free Report) last announced its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 EPS for the quarter, beating the consensus estimate of $1.42 by $0.38. The company had revenue of $600.70 million for the quarter, compared to analyst estimates of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. On average, sell-side analysts predict that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.